Home >> WEBINARS >> On demand webinar—Endeavor to leave no patient behind: Next-generation sequencing (NGS) in routine NSCLC biomarker testing

On demand webinar—Endeavor to leave no patient behind: Next-generation sequencing (NGS) in routine NSCLC biomarker testing

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenter: Boaz Kurtis, MD

What will this webinar empower you to do?

  • To learn the how and why of NGS testing for NSCLC therapy selection
  • How to practice precision oncology based on fast-changing guidelines and to ensure even challenging samples get tested to achieve best outcomes for as many NSCLC patients as possible
  • Cancer Genetics Inc. (CGI) testing model, case studies and lessons learned

Originally broadcast: March 28, 2018

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Thermo Fisher.

x

Check Also

Molecular lung cancer testing: from guideline to practice

August 2018—Testing turnaround times can affect whether non-small cell lung cancer patients receive an EGFR or ALK tyrosine kinase inhibitor when indicated. At disease progression on an EGFR TKI, integrating circulating tumor DNA and tissue-based testing may lessen some of the limitations of each form of testing.

X